2m 2m 2m 2m 2m 2m 2m
Incyte (INCY)
NASDAQ
$116.49-$0.45 (-0.38%)
Price as of Oct 23, 2026 4:20 AM EDT- $23.7BMarket Cap
- 30.93%1-Year Change
- BiotechnologyIndustry
Incyte (INCY)
$116.49-$0.45 (-0.38%)
INCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $116.93 | ||
Change | +$3.49 (+3.08%) | ||
Open | $113.93 | ||
High | $117.17 | ||
Low | $112.76 | ||
Previous Close | $113.44 | ||
Volume | 2,236,051 | ||
30-Day Average Volume | 1,716,542 | ||
1-Week Change | 3.23% | ||
1-Month Change | -7.88% | ||
1-Year Change | 30.93% | ||
3-Year Change | 112.10% | ||
5-Year Change | 77.73% | ||
Fundamentals | |||
Shares Outstanding | 202.7M | ||
Total Assets | $7.9B | ||
Market Cap | $23.7B | ||
Enterprise Value | $19.7B | ||
Period: QTR TTM FY | |||
Revenue | $1.5B | ||
Net Income | $585.6M | ||
Free Cash Flow | $507.7M | ||
EBIT | $751.5M | ||
EBITDA | $778.0M | ||
Net Working Capital | $4.7B | ||
EPS | $2.81 | ||
Enterprise Value/EBITDA | 25 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 4 | ||
P/E | 42 | ||
PEG | 0 | ||
Price/Free Cash Flow | 47 | ||
Price/Operating Cash Flow | 47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue